Defining outcomes for otitis media studies.
Feder
H M
HM
D000658:Amoxicillin / Q000627:therapeutic use*; D019980:Amoxicillin-Potassium Clavulanate Combination; D015296:Ceftizoxime / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002648:Child; D002969:Clavulanic Acids / Q000627:therapeutic use*; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D006801:Humans; D010033:Otitis Media / Q000188:drug therapy*; D011355:Prodrugs / Q000627:therapeutic use*; D016896:Treatment Outcome; D000097627:Cefpodoxime Proxetil
D000658:Amoxicillin; D019980:Amoxicillin-Potassium Clavulanate Combination; D015296:Ceftizoxime; D002969:Clavulanic Acids; D011355:Prodrugs; D000097627:Cefpodoxime Proxetil